AstraZeneca PLC (AZN) Ownership
AZN ownership summary
as of October 18, 2026- Institutions
- 65.1% of shares outstanding
- Insiders
- 0.05% of shares outstanding
- Shares outstanding
- 1.55B
- Float
- 1.54B shares available to trade
- Short interest
- 0.17% 2.6M shares short
- Days to cover
- 0.88 short interest down 9.5% vs prior month
- Institutions 65.10%
- Insiders 0.05%
- Other investors 34.85%
AZN top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Investors Finance Co PLC | 3.33% | 51.6M | $8.53B | — | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 2.93% | 45.4M | $7.51B | +346,048 (+0.8%) | June 30, 2026 |
| 3 | Capital Research & Mgmt Co - Division 3 | 2.23% | 34.6M | $5.72B | +183,057 (+0.5%) | June 30, 2026 |
| 4 | NORGES BANK | 2.18% | 33.9M | $5.60B | +33.9M (0.0%) | June 30, 2026 |
| 5 | Capital World Investors | 1.94% | 30.1M | $4.97B | +1.8M (+6.4%) | June 30, 2026 |
| 6 | FMR Inc | 1.86% | 28.9M | $4.78B | −706,460 (−2.4%) | June 30, 2026 |
| 7 | Wellington Management Company LLP | 1.84% | 28.5M | $4.72B | +4.8M (+20.2%) | June 30, 2026 |
| 8 | Legal & General Group PLC | 1.66% | 25.8M | $4.26B | −99,733 (−0.4%) | June 30, 2026 |
| 9 | JPMorgan Chase & Co | 1.24% | 19.2M | $3.18B | +613,901 (+3.3%) | June 30, 2026 |
| 10 | VANGUARD ASSET MANAGEMENT Ltd | 1.21% | 18.7M | $3.10B | +177,605 (+1.0%) | June 30, 2026 |
| 11 | PRIMECAP Management Company | 1.17% | 18.1M | $2.99B | −118,530 (−0.7%) | June 30, 2026 |
| 12 | Bank of America Corp | 1.14% | 17.7M | $2.93B | −1.4M (−7.2%) | June 30, 2026 |
| 13 | T. Rowe Price Associates, Inc. | 1.07% | 16.6M | $2.75B | −2.9M (−14.7%) | June 30, 2026 |
| 14 | Franklin Templeton Inc | 1.06% | 16.5M | $2.73B | −1.3M (−7.2%) | June 30, 2026 |
| 15 | Amundi | 1.06% | 16.4M | $2.72B | +1.0M (+6.7%) | June 30, 2026 |
| 16 | Vanguard Fiduciary Trust Co | 0.86% | 13.3M | $2.20B | +95,907 (+0.7%) | June 30, 2026 |
| 17 | Deutsche Bank AG | 0.82% | 12.6M | $2.09B | +510,948 (+4.2%) | June 30, 2026 |
| 18 | HHG PLC | 0.77% | 11.9M | $1.98B | +11.9M (0.0%) | March 31, 2026 |
| 19 | Jupiter Topco LLC | 0.77% | 11.9M | $1.96B | +11.9M (0.0%) | June 30, 2026 |
| 20 | DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main | 0.76% | 11.7M | $1.94B | −1.2M (−9.4%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 67.2M shares and 7 cut 7.7M.
AZN top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard Total Intl Stock Index Inv | 1.43% | 22.1M | $3.66B | +74,918 (+0.3%) | August 31, 2026 |
| 2 | American Funds New Perspective A | 1.09% | 16.8M | $2.79B | +1.0M (+6.5%) | June 30, 2026 |
| 3 | Vanguard Developed Markets Index Admiral | 0.95% | 14.7M | $2.43B | −22,462 (−0.2%) | August 31, 2026 |
| 4 | Vanguard PRIMECAP Inv | 0.77% | 11.9M | $1.97B | −98,800 (−0.8%) | June 30, 2026 |
| 5 | iShares Core MSCI EAFE ETF | 0.74% | 11.5M | $1.90B | +29,125 (+0.3%) | September 30, 2026 |
| 6 | Vanguard Health Care Inv | 0.65% | 10.1M | $1.67B | +196,626 (+2.0%) | June 30, 2026 |
| 7 | Goldman Sachs GQG Ptnrs Intl Opps Instl | 0.65% | 10.1M | $1.67B | — | June 30, 2026 |
| 8 | American Funds EUPAC A | 0.64% | 9.9M | $1.63B | −485,027 (−4.7%) | June 30, 2026 |
| 9 | iShares Core FTSE 100 ETF GBP Dist | 0.62% | 9.7M | $1.60B | — | September 30, 2026 |
| 10 | PUTM ACS UK All Shr Lstd EqMultiMgrB£Acc | 0.61% | 9.5M | $1.57B | +1.1M (+13.5%) | September 30, 2026 |
| 11 | Vanguard FTSE UK All Shr Idx Unit Tr£Acc | 0.58% | 9.0M | $1.49B | +7,284 (+0.1%) | August 31, 2026 |
| 12 | UWS UK Index Tracker A - OSB | 0.50% | 7.8M | $1.29B | — | August 31, 2026 |
| 13 | American Funds Capital Inc Bldr A | 0.50% | 7.7M | $1.27B | −62,330 (−0.8%) | June 30, 2026 |
| 14 | Fidelity International Index | 0.38% | 6.0M | $987.0M | +88,010 (+1.5%) | August 31, 2026 |
| 15 | iShares MSCI EAFE ETF | 0.35% | 5.4M | $891.4M | — | September 30, 2026 |
| 16 | FID DC L&G LB UK Equity Index N | 0.32% | 4.9M | $808.6M | −149,579 (−3.0%) | June 30, 2026 |
| 17 | American Funds Income Fd of Amer A | 0.29% | 4.5M | $751.2M | — | June 30, 2026 |
| 18 | UWS Aviva Azionario Small And Mid-Cap | 0.25% | 4.0M | $653.7M | +67,864 (+1.7%) | July 31, 2026 |
| 19 | Vanguard FTSE 100 UCITS ETF | 0.25% | 3.8M | $635.3M | −8,784 (−0.2%) | August 31, 2026 |
| 20 | L&G UK Index I Acc | 0.25% | 3.8M | $633.8M | +18,730 (+0.5%) | July 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
AZN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns AZN
Institutional investors own 65.1% of AstraZeneca's shares and insiders 0.05%. The largest holder is Investors Finance Co PLC with 3.33% of the shares (51.6M), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 7 reduced their stake in the latest filings. Short interest is 0.17% of the float, or 0.88 days of average trading volume. The share count rose 23.5% since 2014.
Related: AZN analyst forecast, AZN key metrics, AZN dividend history. See the AZN stock overview for the latest quote and news.
AZN ownership FAQ
Who owns the most AstraZeneca stock?
The largest shareholders of AstraZeneca are Investors Finance Co PLC (3.33%), Vanguard Capital Management, LLC (2.93%), Capital Research & Mgmt Co - Division 3 (2.23%), NORGES BANK (2.18%), Capital World Investors (1.94%).
What percentage of AstraZeneca is owned by institutions?
Institutions hold 65.1% of AstraZeneca's shares outstanding; insiders hold 0.05%.
Which funds own AstraZeneca?
The largest fund holders of AstraZeneca are Vanguard Total Intl Stock Index Inv (1.43%), American Funds New Perspective A (1.09%), Vanguard Developed Markets Index Admiral (0.95%), Vanguard PRIMECAP Inv (0.77%), iShares Core MSCI EAFE ETF (0.74%).
What is AstraZeneca's short interest?
2.6M shares of AstraZeneca were sold short, 0.17% of the float; at the average daily volume it would take 0.88 days to cover.
How many shares of AstraZeneca are outstanding?
AstraZeneca has 1.55B shares outstanding, of which 1.54B are in the public float.